Esai and Biogen, Lequembi manufacturer, receive FDA approval for Alzheimer's drug. Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review. Source 8o.
Sponsored Links:
Post Date:Mon May 13 18:23:25 GMT 2024 / Post ID: #
Comment
Lecanemab
Looking for more on lecanemab should be elaborated now so that hopefully get and maybe get a better idea.
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,
Add Reply
Add Comment As A Guest
Close Topic Options